Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

31.4400 USD 1.6800 5.07%

As of 20:10:00 ET on 04/27/2015.

Snapshot for Acorda Therapeutics Inc (ACOR)

Open: 33.3200 Day's Range: 31.2100 - 33.3800 Volume: 707,031
Previous Close: 33.1200 52wk Range: 28.2600 - 45.4500 1-Yr Rtn: -7.45%

Stock Chart for ACOR

No chart data available.
  • ACOR:US 31.4500
  • 1D
  • 1M
  • 1Y
33.1200
Interactive ACOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACOR

Current P/E Ratio (ttm) 45.7097
Estimated P/E(12/2015) 68.0519
Relative P/E vs. SPX 2.4559
Earnings Per Share (USD) (ttm) 0.6878
Est. EPS (USD) (12/2015) 0.4620
Est. PEG Ratio 2.1266
Market Cap (M USD) 1,338.57
Shares Outstanding (M) 42.58
30 Day Average Volume 586,454
Price/Book (mrq) 2.4374
Price/Sale (ttm) 3.2244
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACOR

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
More Company Profile & Key Executives for ACOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil